Adicet Bio Stock Analysis
| ACET Stock | USD 1.47 0.16 9.82% |
Adicet Bio is undervalued with Real Value of 6.17 and Target Price of 20.33. The main objective of Adicet Bio stock analysis is to determine its intrinsic value, which is an estimate of what Adicet Bio is worth, separate from its market price. There are two main types of Adicet Bio's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Adicet Bio's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Adicet Bio's stock to identify patterns and trends that may indicate its future price movements.
The Adicet Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Adicet Bio is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Adicet Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Adicet Bio's ongoing operational relationships across important fundamental and technical indicators.
Adicet |
Adicet Stock Analysis Notes
About 66.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.04. Some equities with similar Price to Book (P/B) outperform the market in the long run. Adicet Bio has Price/Earnings To Growth (PEG) ratio of 0.82. The entity recorded a loss per share of 3.31. The firm last dividend was issued on the 16th of September 2020. Adicet Bio had 1:7 split on the 16th of September 2020. Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 86 people. For more info on Adicet Bio please contact BA CPA at 650 503 9095 or go to https://www.adicetbio.com.Adicet Bio Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Adicet Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Adicet Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Adicet Bio generated a negative expected return over the last 90 days | |
| Adicet Bio may become a speculative penny stock | |
| Adicet Bio has high historical volatility and very poor performance | |
| Net Loss for the year was (142.66 M) with profit before overhead, payroll, taxes, and interest of 24.99 M. | |
| Adicet Bio currently holds about 260.64 M in cash with (93.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 66.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from businesswire.com: Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635 |
Adicet Bio Upcoming and Recent Events
Earnings reports are used by Adicet Bio to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Adicet Bio previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Adicet Largest EPS Surprises
Earnings surprises can significantly impact Adicet Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2016-06-30 | 2016-06-30 | 0.39 | 0.35 | -0.04 | 10 | ||
2022-03-15 | 2021-12-31 | -0.42 | -0.47 | -0.05 | 11 | ||
2023-08-09 | 2023-06-30 | -0.68 | -0.75 | -0.07 | 10 |
Adicet Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Adicet Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Adicet Bio backward and forwards among themselves. Adicet Bio's institutional investor refers to the entity that pools money to purchase Adicet Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | State Street Corporation | 2023-12-31 | 640.5 K | Acadian Asset Management Llc | 2023-12-31 | 559.8 K | Two Sigma Advisers, Llc | 2023-12-31 | 520 K | Norges Bank | 2023-12-31 | 429.6 K | Two Sigma Investments Llc | 2023-12-31 | 360.7 K | Northern Trust Corp | 2023-12-31 | 232.1 K | Nuveen Asset Management, Llc | 2023-12-31 | 193.8 K | Dimensional Fund Advisors, Inc. | 2023-12-31 | 153.4 K | Fmr Inc | 2023-12-31 | 135.9 K | Orbimed Advisors, Llc | 2023-12-31 | 8.3 M | Rtw Investments, Llc | 2023-12-31 | 4.1 M |
Adicet Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 134.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Adicet Bio's market, we take the total number of its shares issued and multiply it by Adicet Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Adicet Profitablity
Adicet Bio's profitability indicators refer to fundamental financial ratios that showcase Adicet Bio's ability to generate income relative to its revenue or operating costs. If, let's say, Adicet Bio is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Adicet Bio's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Adicet Bio's profitability requires more research than a typical breakdown of Adicet Bio's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.69) | (0.65) | |
| Return On Capital Employed | (0.71) | (0.67) | |
| Return On Assets | (0.69) | (0.65) | |
| Return On Equity | (0.84) | (0.80) |
Management Efficiency
Adicet Bio has return on total asset (ROA) of (0.308) % which means that it has lost $0.308 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6169) %, meaning that it created substantial loss on money invested by shareholders. Adicet Bio's management efficiency ratios could be used to measure how well Adicet Bio manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.65 in 2024. Return On Capital Employed is likely to gain to -0.67 in 2024. Total Current Liabilities is likely to drop to about 18.3 M in 2024. Liabilities And Stockholders Equity is likely to drop to about 165.2 M in 2024| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.95 | 3.76 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | 3.95 | 4.15 | |
| Enterprise Value Over EBITDA | 0.45 | 0.48 | |
| Price Book Value Ratio | 0.48 | 0.45 | |
| Enterprise Value Multiple | 0.45 | 0.48 | |
| Price Fair Value | 0.48 | 0.45 | |
| Enterprise Value | -57.4 M | -54.6 M |
The analysis of Adicet Bio's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Adicet Bio's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Adicet Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.762 |
Technical Drivers
As of the 11th of May 2024, Adicet Bio shows the Risk Adjusted Performance of (0.11), mean deviation of 3.81, and Standard Deviation of 4.85. Adicet Bio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Adicet Bio, which can be compared to its peers. Please confirm Adicet Bio coefficient of variation and maximum drawdown to decide if Adicet Bio is priced correctly, providing market reflects its regular price of 1.47 per share. Please also double-check Adicet Bio jensen alpha, which is currently at (0.91) to validate the company can sustain itself at a future point.Adicet Bio Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Adicet Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Adicet Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Adicet Bio Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Adicet Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Adicet Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Adicet Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Schor Chen over six months ago Acquisition by Schor Chen of 240000 shares of Adicet Bio subject to Rule 16b-3 | ||
Schor Chen over six months ago Sale by Schor Chen of 5500 shares of Adicet Bio | ||
Silverstein Jonathan over a year ago Conversion by Silverstein Jonathan of 2425482 shares of Adicet Bio | ||
Schor Chen over a year ago Bona fide gift to Schor Chen of 26712 shares of Adicet Bio subject to Section 16 |
Adicet Bio Predictive Daily Indicators
Adicet Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Adicet Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 146662.0 | |||
| Daily Balance Of Power | (0.59) | |||
| Rate Of Daily Change | 0.9 | |||
| Day Median Price | 1.6 | |||
| Day Typical Price | 1.55 | |||
| Price Action Indicator | (0.20) | |||
| Period Momentum Indicator | (0.16) |
Adicet Bio Forecast Models
Adicet Bio's time-series forecasting models are one of many Adicet Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Adicet Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Adicet Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Adicet Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Adicet shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Adicet Bio. By using and applying Adicet Stock analysis, traders can create a robust methodology for identifying Adicet entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (3.21) | (3.37) | |
| Operating Profit Margin | (3.34) | (3.51) | |
| Net Loss | (3.08) | (3.24) | |
| Gross Profit Margin | 0.72 | 0.76 |
Current Adicet Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Adicet analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Adicet analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 20.33 | Strong Buy | 8 | Odds |
Most Adicet analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Adicet stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Adicet Bio, talking to its executives and customers, or listening to Adicet conference calls.
Adicet Stock Analysis Indicators
Adicet Bio stock analysis indicators help investors evaluate how Adicet Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Adicet Bio shares will generate the highest return on investment. By understating and applying Adicet Bio stock analysis, traders can identify Adicet Bio position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 257.7 M | |
| Common Stock Shares Outstanding | 43 M | |
| Total Stockholder Equity | 170.2 M | |
| Property Plant And Equipment Net | 44.2 M | |
| Cash And Short Term Investments | 159.7 M | |
| Cash | 159.7 M | |
| Accounts Payable | 2.6 M | |
| Net Debt | -138.8 M | |
| 50 Day M A | 2.0818 | |
| Total Current Liabilities | 19.3 M | |
| Other Operating Expenses | 132.6 M | |
| Non Current Assets Total | 45 M | |
| Non Currrent Assets Other | 822 K | |
| Stock Based Compensation | 20.3 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adicet Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.Note that the Adicet Bio information on this page should be used as a complementary analysis to other Adicet Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Adicet Stock analysis
When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Adicet Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adicet Bio. If investors know Adicet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adicet Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.31) | Quarterly Revenue Growth (1.00) | Return On Assets (0.31) | Return On Equity (0.62) |
The market value of Adicet Bio is measured differently than its book value, which is the value of Adicet that is recorded on the company's balance sheet. Investors also form their own opinion of Adicet Bio's value that differs from its market value or its book value, called intrinsic value, which is Adicet Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adicet Bio's market value can be influenced by many factors that don't directly affect Adicet Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adicet Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adicet Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adicet Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.